Inhibrx Biosciences, Inc. · NASDAQ:INBX
Lappe Mark bought 25,000 Inhibrx Biosciences, Inc. shares (Form 4)
Traded Sep 8, 2026 · Filed Sep 8, 2026
On Sep 8, 2026, Lappe Mark (Director, Chief Executive Officer) bought 25,000 Inhibrx Biosciences, Inc. shares at an average US$105.81 for US$2.65M, leaving 730,548 shares. Filed Sep 8, 2026 (Form 4).
- Bought
- 25,000 shares
- Price
- US$105.81 average (US$99.29 to US$112.28)
- Value
- US$2.65M
- Holding after
- 730,548 shares (held indirectly)
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Stock | Buy | 5,895 | US$99.29 | 711,443 | Indirect |
| Sep 8, 2026 | Common Stock | Buy | 6,605 | US$100.64 | 718,048 | Indirect |
| Sep 8, 2026 | Common Stock | Buy | 1,100 | US$107.12 | 719,148 | Indirect |
| Sep 8, 2026 | Common Stock | Buy | 500 | US$108.24 | 719,648 | Indirect |
| Sep 8, 2026 | Common Stock | Buy | 1,219 | US$111.88 | 720,867 | Indirect |
| Sep 8, 2026 | Common Stock | Buy | 9,681 | US$112.28 | 730,548 | Indirect |
Source
Related
- Inhibrx Biosciences, Inc.
- Lappe Mark
- Inhibrx Biosciences, Inc. shareholders
- Form 4 · Lappe Mark · Oct 14, 2026
- Form 4 · Lappe Mark · Sep 28, 2026
- Form 4 · Kayyem Jon Faiz · Sep 23, 2026
- Form 4 · Kayyem Jon Faiz · Sep 17, 2026
- Form 4 · Manhard Kimberly · Sep 15, 2026
- Form 4 · Manhard Kimberly · Sep 10, 2026
- Form 4 · Kayyem Jon Faiz · Sep 8, 2026